Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

THG strikes deal with Greencore to sell protein-enriched convenience foods

(Sharecast News) - THG is to target the booming obesity jab market through a strategic partnership with convenience food producer Greencore Group, it confirmed on Thursday. Under the terms of the deal, financial details of which were not disclosed, Greencore will produce a range of on-the-go convenience foods, including salads and wraps, under THG's Myprotein sports nutrition brand.

The range will be sold in Sainsbury's supermarkets and convenience stores.

Neil Mistry, chief executive of THG Nutrition, said: "The range builds on the demand of GLP-1 consumers, along with trends towards cleaner nutrition combined with protein-rich foods and snacks.

"This partnership not only widens the reach of the Myprotein brand offering, it brings further significant penetration into offline channels."

Andy Parton, Greencore's chief commercial officer, said: "As demand grows for convenient, nutritious products that support healthier lifestyles, this collaboration allows us to combine Greencore's expertise...with one of the most recognisable brands in sports nutrition."

Used for the treatment of both diabetes and obesity, demand for GLP-1 drugs such as Ozempic and Mounjaro has boomed in recent years. UBS currently expects sales to reach $130bn by the end of the decade, with around 52m patients taking a GLP-1 in 2030, up from 13m in 2024.

Users are advised to increase protein intake, to help prevent muscle loss during rapid weight loss.

The Greencore partnership is the latest in a number of licensing agreements struck by THG for its nutrition brands, including Muller, Iceland and Jimmy's Coffee. It is targeting selling-in over 60m licensed products this year, up from 43m in 2025.

As at 0900 GMT, Greencore was down 5% at 279.25p, while THG was 2% higher at 36.08p.

Share this article

Related Sharecast Articles

Ibstock earnings dip as expected in 'progressively tougher market'
(Sharecast News) - Building products manufacturer Ibstock reported a drop in full-year earnings on Thursday, in line with revised guidance, in a "progressively tougher market".
OSB hikes dividend, launches buyback after fall in profit
(Sharecast News) - OSB Group reported a decline in annual profit for 2025 on Thursday as higher administrative costs and an impairment charge weighed on earnings, though the specialist lender said loan growth and originations increased and it announced a £100m share buyback alongside a higher dividend.
Spire Healthcare grows annual profits, but NHS outlook uncertain in 2026
(Sharecast News) - Takeover target and Spire Healthcare reported a small rise in adjusted profits over 2025 which it hailed as a "resilient performance" against a backdrop of significant cost headwinds, though the outlook for 2026 was proving more uncertain due to a drop in NHS commissioning activity.
Bloomsbury shares spark on 2027 profit outlook
(Sharecast News) - Shares in Bloomsbury Publishing shot higher on Thursday after it said profit for the year ending 28 February 2027 was set to be "materially ahead" of market expectations as Sarah J. Maas will publish her next two novels within the next year.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.